Conference Proceedings
LBH589, a novel deacetylase inhibitor (DACI), in the treatment of cutaneous T-cell lymphoma (CTCL): Changes in tumor gene expression profiles related to clinical response after therapy
Y Pan, HM Prince, J George, RW Johnstone, L Ellis, C McCormack, GK Smyth, R Williams-Truax, P Atadja, D Butterfoss, M Dugan, K Culver
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | FERRATA STORTI FOUNDATION | Published : 2007